5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy

Magnetic Resonance in Medicine

Volumn 36, Issue 3, 1996, Pages 445-450

  Kamm, Yvonne J L ^a   Heerschap, Arend ^a   Rosenbusch, Gert ^a   Rietjens, Ivonne M C M ^b   Vervoort, Jacques ^b   Wagener, D J Theo ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

5 fluorouracil; 19F NMR spectroscopy; metabolism; necrosis

Indexed keywords

AMINO ACIDS; CELL DEATH; MAMMALS; METABOLISM; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

19F NMR; 5-FLUOROURACIL; 5-FLUOROURACIL (5-FU); COLON CARCINOMA; HIGH RESOLUTION; NECROSIS; NECROTIC TISSUE; PERCHLORIC ACIDS;

TUMORS;

FLUORINE; FLUOROURACIL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; COLON CARCINOMA; CONTROLLED STUDY; DRUG METABOLISM; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TISSUE NECROSIS; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0029737891     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910360317     Document Type: Article

References (22)

1. C. Heidelberger, P. V. Danenberg, R. G. Moran, Fluorinated pyrimidines and their nucleosides. Adv. Enzymol. 54, 57-119 (1983).
2. H. M. Pinedo, G. F. Peters, Fluorouracil: biochemistry and pharmacology. J. Clin. Oncol. 6, 1653-1664 (1988).
3. J. L. Grem, In "Cancer Chemotherapy: Principles and Practice" (B. A. Chabner, J. M. Collins, Eds.), pp. 180-224. Lippincott Co., Philadelphia, 1990.
4. 19F MRS studies of fluoropyrimidine chemotherapy. A review. NMR Biomed. 2, 133-141 (1989).
5. 19F nuclear magnetic resonance spectroscopy. Cancer Res. 54, 4321-4326 (1994).
6. 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver. Cancer Res. 51, 1384-1390 (1991).
7. 19F-MRS study in vivo. Br. J. Cancer 65, 369-375 (1992).
8. 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study. Ann. Oncol. 4, 597-602 (1993).
9. G. J. Peters, J. van Dijk, J. C. Nadal, C. J. van Groeningen, J. Lankelma, H. M. Pinedo, Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In vivo 1, 113-118 (1987).
10. 19F NMR spectroscopy. Magn. Reson. Med. 19, 113-123 (1991).
11. V. T. De Vita, In "Cancer - Principles and Practice of Oncology" (V. T. De Vita, S. Hellman, A. Rosenberg, Eds.), pp. 276-300, Lippincott Co., Philadelphia, 1989.
12. G. H. Blijham, Chemotherapy of colorectal rancor. Anti-Cancer Drugs 2, 233-245 (1991).
13. O. N. Keene, The log transformation is special. Stat. Med. 14, 811-819 (1995).
14. 19F-NMR of tissues ex vivo, In "Proc., SMRM, 13th Annual Meeting, New York, 1993," p. 1016.
15. 19F-NMR spectroscopy. J. Cancer Res. Clin. Oncol. 117, 295-304 (1991).
16. 19F-NMR spectroscopic observation of 5-fluorouracil metabolism in the isolated perfused mouse liver model. NMR Biomed. 1, 113-120 (1988).
17. 19F NMR spectroscopy. Magn. Reson. Med. 19, 113-123 (1991).
18. 19F NMR spectroscopy. NMR Biomed. 4, 274-278 (1991).
19. 19F nuclear magnetic resonance spectroscopy. Cancer Res. 51, 5806-5812 (1991).
20. M. Keniry, C. Benz, R. H. Shafer, T. L. James, Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res. 46, 1754-1758 (1986).
21. 19F nuclear magnetic resonance spectroscopy. Cancer Res. 1, 5770-5773 (1991).
22. J. Denekamp, The choice of experimental models in cancer research: the key to ultimate success or failure? NMR Biomed. 5, 234-237 (1992).